285 related articles for article (PubMed ID: 32241059)
1. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma].
Xie ZH; Li J; Xia Y; Shen F
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059
[TBL] [Abstract][Full Text] [Related]
2. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Ross JS; Wang K; Gay L; Al-Rohil R; Rand JV; Jones DM; Lee HJ; Sheehan CE; Otto GA; Palmer G; Yelensky R; Lipson D; Morosini D; Hawryluk M; Catenacci DV; Miller VA; Churi C; Ali S; Stephens PJ
Oncologist; 2014 Mar; 19(3):235-42. PubMed ID: 24563076
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic Cholangiocarcinoma.
El-Diwany R; Pawlik TM; Ejaz A
Surg Oncol Clin N Am; 2019 Oct; 28(4):587-599. PubMed ID: 31472907
[TBL] [Abstract][Full Text] [Related]
4. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
Brown ZJ; Hewitt DB; Pawlik TM
Front Biosci (Landmark Ed); 2022 Mar; 27(3):85. PubMed ID: 35345317
[TBL] [Abstract][Full Text] [Related]
6. [Progress on surgical treatment of intrahepatic cholangiocarcinoma].
Shen F; Xie ZH; Xia Y; Wu MC
Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):241-246. PubMed ID: 30929367
[TBL] [Abstract][Full Text] [Related]
7. The focus clinical research in intrahepatic cholangiocarcinoma.
Song Y; Cai M; Li Y; Liu S
Eur J Med Res; 2022 Jul; 27(1):116. PubMed ID: 35820926
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary approaches to intrahepatic cholangiocarcinoma.
Maithel SK; Gamblin TC; Kamel I; Corona-Villalobos CP; Thomas M; Pawlik TM
Cancer; 2013 Nov; 119(22):3929-42. PubMed ID: 23963845
[TBL] [Abstract][Full Text] [Related]
9. The current role of radiotherapy and systemic therapy in the multidisciplinary treatment of cholangiocarcinoma.
Soumarová R; Gürlich R; Hajer J; Oliverius M; Kubecová M; Šejdová M; Liberko M; Kološtová K
Cas Lek Cesk; 2019; 158(2):78-82. PubMed ID: 31109168
[TBL] [Abstract][Full Text] [Related]
10. Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review.
Bressler L; Bath N; Manne A; Miller E; Cloyd JM
Chin Clin Oncol; 2023 Apr; 12(2):15. PubMed ID: 37038054
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
12. [New advances in the diagnosis and treatment of intrahepatic cholangiocarcinoma].
Qin DL; Chen JL; Tang Y; Li ZL; Tang ZH; Quan ZW
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):331-337. PubMed ID: 38432675
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.
Chang WW; Hsiao PK; Qin L; Chang CL; Chow JM; Wu SY
Radiother Oncol; 2018 Nov; 129(2):284-292. PubMed ID: 30279046
[TBL] [Abstract][Full Text] [Related]
14. Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma.
Li F; Peiris MN; Donoghue DJ
Cytokine Growth Factor Rev; 2020 Apr; 52():56-67. PubMed ID: 31899106
[TBL] [Abstract][Full Text] [Related]
15. Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma.
Huang SB; Zheng CX
Expert Rev Anticancer Ther; 2017 Jan; 17(1):89-96. PubMed ID: 27893290
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches.
Guro H; Kim JW; Choi Y; Cho JY; Yoon YS; Han HS
Surg Oncol; 2017 Jun; 26(2):146-152. PubMed ID: 28577720
[TBL] [Abstract][Full Text] [Related]
17. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.
Sia D; Tovar V; Moeini A; Llovet JM
Oncogene; 2013 Oct; 32(41):4861-70. PubMed ID: 23318457
[TBL] [Abstract][Full Text] [Related]
19. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
Topaloğlu S; Sağlam K; Çalık A; Cobanoğlu Ü; Öztürk MH
Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
[TBL] [Abstract][Full Text] [Related]
20. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
Hong K; Geschwind JF
Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]